170 related articles for article (PubMed ID: 26141216)
41. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
42. Impact of minimal solid and micropapillary components on invasive lung adenocarcinoma recurrence.
Chen C; Chen ZJ; Li WJ; Pan XF; Wen YY; Deng T; Le HB; Zhang YK; Zhang BJ
Ann Diagn Pathol; 2022 Aug; 59():151945. PubMed ID: 35397312
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of MMP9 activity level in resected stage I B lung adenocarcinoma.
Yu Y; Ding Z; Jian H; Shen L; Zhu L; Lu S
Cancer Med; 2016 Sep; 5(9):2323-31. PubMed ID: 27456862
[TBL] [Abstract][Full Text] [Related]
44. Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma.
Yoshida T; Ishii G; Goto K; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Nagai K; Ohe Y; Ochiai A
J Cancer Res Clin Oncol; 2013 Oct; 139(10):1691-700. PubMed ID: 23974272
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
46. Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor Cells.
Cruz-Rico G; Avilés-Salas A; Popa-Navarro X; Lara-Mejía L; Catalán R; Sánchez-Reyes R; López-Sánchez D; Cabrera-Miranda L; Aquiles Maldonado-Martínez H; Samtani-Bassarmal S; Arrieta O
Pathol Oncol Res; 2021; 27():597499. PubMed ID: 34257548
[No Abstract] [Full Text] [Related]
47. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
[TBL] [Abstract][Full Text] [Related]
48. Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
Sun Y; Yu X; Shi X; Hong W; Zhao J; Shi L
World J Surg Oncol; 2014 May; 12():148. PubMed ID: 24885205
[TBL] [Abstract][Full Text] [Related]
49. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
[TBL] [Abstract][Full Text] [Related]
50. Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients.
Wang T; Zhang Y; Liu B; Hu M; Zhou N; Zhi X
Thorac Cancer; 2017 Nov; 8(6):600-605. PubMed ID: 28940943
[TBL] [Abstract][Full Text] [Related]
51. Histopathology of lung adenocarcinoma based on new IASLC/ATS/ERS classification: prognostic stratification with functional and metabolic imaging biomarkers.
Lee HY; Jeong JY; Lee KS; Yi CA; Kim BT; Kang H; Kwon OJ; Shim YM; Han J
J Magn Reson Imaging; 2013 Oct; 38(4):905-13. PubMed ID: 23908132
[TBL] [Abstract][Full Text] [Related]
52. Cribriform Subtype is an Independent Predictor of Recurrence and Survival After Adjustment for the Eighth Edition of TNM Staging System in Patients With Resected Lung Adenocarcinoma.
Kadota K; Kushida Y; Kagawa S; Ishikawa R; Ibuki E; Inoue K; Go T; Yokomise H; Ishii T; Kadowaki N; Haba R
J Thorac Oncol; 2019 Feb; 14(2):245-254. PubMed ID: 30336325
[TBL] [Abstract][Full Text] [Related]
53. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
54. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
J Thorac Oncol; 2013 May; 8(5):612-8. PubMed ID: 23584293
[TBL] [Abstract][Full Text] [Related]
55. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
[TBL] [Abstract][Full Text] [Related]
56. Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
Driver BR; Miller RA; Miller T; Deavers M; Gorman B; Mody D; Ge Y; Barrios R; Bernicker E; Kim M; Cagle PT
Arch Pathol Lab Med; 2017 Nov; 141(11):1529-1532. PubMed ID: 28829153
[TBL] [Abstract][Full Text] [Related]
57. [Correlation of caveolin-1 expression with clinicopathologic features and prognosis in patients with lung adenocarcinoma].
Wang Y; Liu B; Xu Y; Zhang J; Xia Q; Yu B; Zhang R; Shi S; Lu Z; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):251-5. PubMed ID: 24915816
[TBL] [Abstract][Full Text] [Related]
58. Validation Study of New IASLC Histology Grading System in Stage I Non-Mucinous Adenocarcinoma Comparing With Minimally Invasive Adenocarcinoma.
Woo W; Cha YJ; Kim BJ; Moon DH; Lee S
Clin Lung Cancer; 2022 Nov; 23(7):e435-e442. PubMed ID: 35945128
[TBL] [Abstract][Full Text] [Related]
59. [Expression of CD10 in tumor-associated fibroblast of cancerized or recurrent colorectal adenomas].
Zheng J; Zhu Y; Li C; Li Y; Nie Q; Zhu Z; Deng H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):335-341. PubMed ID: 27868405
[TBL] [Abstract][Full Text] [Related]
60. [Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma].
Ding FG; Liu B; Zhang XH; Xu Y; Yu B; Zhang RS; He Y; Ma HH; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):145-50. PubMed ID: 22800475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
